Analysis of Mammalian Septin Expression in Human Malignant Brain Tumors  by Kim, Dong-Seok et al.
Analysis of Mammalian Septin Expression in Human
Malignant Brain Tumors1
Dong-Seok Kim, Sherri-Lynn Hubbard, Aurelia Peraud, Bodour Salhia, Keiichi Sakai and James T. Rutka
The Arthur and Sonia Labatt Brain Tumor Research Centre and Division of Neurosurgery, The Hospital for Sick
Children, The University of Toronto, Toronto, Ontario, Canada
Abstract
Septins are a highly conserved subfamily of GTPases
that play an important role in the process of cytokine-
sis. To increase our understanding of the expression
and localization of the different mammalian septins in
human brain tumors, we used antibodies against
septins 2, 3, 4, 5, 6, 7, 9, and 11 in immunofluor-
escence and Western blot analyses of astrocytomas
and medulloblastomas. We then characterized the
expression and subcellular distribution of the SEPT2
protein in aphidicolin-synchronized U373 MG astrocy-
toma cells by immunofluorescence and fluorescence-
activated cell sorter analysis. To determine the role of
SEPT2 in astrocytoma cytokinesis, we inducibly ex-
pressed a dominant-negative (DN) SEPT2 mutant in
U373 MG astrocytoma cells. We show variable levels
and expression patterns of the different septins in
brain tissue, brain tumor specimens, and human brain
tumor cell lines. SEPT2 was abundantly expressed in
all brain tumor samples and cell lines studied. SEPT3
was expressed in medulloblastoma specimens and
cell lines, but not in astrocytoma specimens or cell
lines. SEPT2 expression was cell cycle–related, with
maximal levels in G2-M. Immunocytochemical analysis
showed endogenous levels of the different septins
within the perinuclear and peripheral cytoplasmic
regions. In mitosis, SEPT2 was concentrated at the
cleavage furrow. By immunocytochemistry and flow
cytometry, we show that a DN SEPT2 mutant inhibits
the completion of cell division and results in the
accumulation of multinucleated cells. These results
suggest that septins are variably expressed in human
brain tumors. Stable expression of the DN SEPT2
mutant leads to a G2-M cell cycle block in astrocytoma
cells.
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Introduction
Septins are a highly conserved subfamily of GTPases that
play an important role in the process of cytokinesis. The
septins were first identified in the budding yeast, Saccha-
romyces cerevisiae, but have also been found in a variety of
other fungi and animals [1–4]. Mutations in any of four yeast
septin genes, Cdc3p, Cdc10p, Cdc11p, and Cdc12p, lead to
deficiencies in hetero-oligomeric filaments that lie adjacent to
the membrane at the mother-bud neck and give rise to abnor-
mally elongated buds unable to complete cytokinesis [5]. The
conserved requirement for septins in cell division was also
revealed by the discovery that the Pnut gene in Drosophila
melanogaster encoded a septin homologue. As in yeast, the
three septins of Drosophila, Pnut, Sep1, and Sep2, also form
7-nm hetero-oligomeric filaments in vitro and these septin
complexes accumulate at the cleavage furrow of mitotic cells
[6]. Mutations in the Pnut gene result in the formation of
multinucleated syncytia in imaginal discs during larval devel-
opment due to failure to complete cytokinesis [1,7]. Similarly,
mutations in the septins UNC-59 and UNC-61 of Caenorhabdi-
tis elegans result in some postembryonic defects in cell division
[8]. Taken together, these data indicate that the septins play an
important role in maintaining cytoskeletal structures necessary
for the control of cell division, and are required for cytokinesis in
flies [1,7], nematodes [8], and mammals [4].
To date, at least 10 mammalian septin homologues have
been described. As the nomenclature for mammalian septins
has recently been revised by Macara et al. [9], we shall refer to
them by their symbols as approved by the Human Genome
Organization Gene Nomenclature Committee. They are now
referred to as SEPT1 to SEPT10 [4,10–21]. Most of these
were identified through random sequencing strategies, sub-
tractive screens, or as candidate genes within disease loci. All
human septins have molecular masses in the range of 30 to
80 kDa and share considerable amino acid sequence identity.
All except SEPT2 and SEPT7 have a GTP-binding domain
near the N-terminus and a predicted coiled-coil motif near the
carboxyl terminus [4]. The identification of septin homologues
Address all correspondence to: James T. Rutka, Division of Neurosurgery, Suite 1502,
Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada M5G 1X8.
E-mail: james.rutka@sickkids.ca
1Dong-Seok Kim was supported by a postdoctoral fellowship program from the Korea Science
and Engineering Foundation (KOSEF). This work was supported, in part, by grants from the
Canadian Institutes of Health Research, the Laurie Berman Fund for Brain Tumor Research,
the Wiley Fund, and Brainchild (to J.T.R.). Aurelia Peraud was funded by the Deutsche
Forschungsgemeinschaft (Pe 758/2-1).
Received 4 September 2003; Revised 24 November 2003; Accepted 26 November 2003.
Copyright D 2004 Neoplasia Press, Inc. All rights reserved 1522-8002/04/$25.00
Neoplasia . Vol. 6, No. 2, March/April 2004, pp. 168 –178 168
www.neoplasia.com
RESEARCH ARTICLE
and molecules that functionally interact with septins in higher
eukaryotes may provide clues to their functions in cytokine-
sis [1,4,6,22,23].
In our previous study, we showed that transient transfec-
tion of an antisense SEPT2 expression vector led to the
failure of cytokinesis in U373 astrocytoma cells [10]. To
further our understanding of the role of human septins in
human brain tumors, here we characterize the expression
and subcellular distribution of eight mammalian septins in a
series of human brain tumor specimens and cell lines. Using
a dominant-negative (DN) approach in stably transfected cell
lines, we have now examined the role of persistent SEPT2
inhibition in cytokinesis and cell division. Our results suggest
that the septins are variably expressed in different human
brain tumor cell lines and tumor specimens, and within
different subcellular compartments in the cell lines exam-
ined. Our observations also suggest a conserved require-
ment for SEPT2 in U373 astrocytoma cell division.
Materials and Methods
Cell Lines and Cell Culture Conditions
The permanent human glioma cell lines U138, U251,
SF-126, SF-188, and SF-539 were obtained from Dolores
Dougherty (The Brain Tumor Research Center, University of
California San Francisco, San Francisco, CA); U343 astro-
cytoma, U373 MG (malignant glioma), and U87 MG were a
generous gift of Bengt Westermark (Uppsala, Sweden). The
Daoy medulloblastoma cell line was obtained from the ATCC
(Manassis, VA). The PFSK supratentorial PNET cell line was
a gift from Dr. Dan Fults, University of Utah (Salt Lake City,
UT). All cell lines have been previously well characterized
[24–27]. Primary cultures of human fibroblasts were initiated
from human foreskin specimens. Permission to use these
materials was granted by the Research Ethics Board (REB)
at The Hospital for Sick Children (Toronto, Ontario, Canada).
All cell lines and cultures were grown in monolayer and
maintained in alpha minimal essential medium (a-MEM) or
Dulbecco’s modified essential medium (DMEM) supple-
mented with 10% fetal calf serum (FCS) and a 1% antibiot-
ic/antifungal mixture (Cellgro, Mediatech, Molecular
Research Laboratories, Herndon, VA) in a humidified atmo-
sphere of 5%CO2 in air at 37jC. Inducible expression of wild-
type and mutant-type SEPT2–green fluorescent protein
(GFP) fusion protein in the U373 MG cell line was accom-
plished using the tetracycline-repressor gene expression
system as previously described [28]. Briefly, stably trans-
fected U373 MG cells (U373 Tet cells) were maintained in
culture containing 300 mg/ml hygromycin and 500 mg/ml
geneticin (G418 sulfate; Gibco-BRL, Gaithersburg, MD).
Wild-type and DN mutant SEPT2–GFP fusion protein ex-
pression was induced by 48 hours of treatment with 4 mg/ml
tetracycline.
Antibodies and Regents
Antibodies to septins 2, 3, 4, 5, 6, 7, 9, and a novel septin
represented by clones FLJ10849 and AL110300 and here-
after called Septin 11, were generated by immunizing rabbits
with synthetic peptides generated against unique regions of
the N-termini of these proteins. These sequences were not
shared with any other polypeptides in the GenBank data-
base. Antibodies to Septins 2, 4, 5, and 9 have been
described elsewhere [29–33] and were provided by William
Trimble (Program in Cell Biology, The Hospital for Sick
Children). All antibodies used in this study are specific for
the corresponding septins with no cross-reactivity to other
septins or any other proteins. Western and immunocyto-
chemical signals are completely abrogated by preincubation
of the antibody with an excess of the corresponding pep-
tide. Details of the antibody generation will be published
elsewhere.
In order to detect the expression of GFP and its fusion
protein, an anti–a-GFP polyclonal antibody (Clontech, Palo
Alto, CA) was used at 1:250 for Western blot analysis. A goat
anti–rabbit IgG HRP conjugate (Bio-Rad, Hercules, CA) was
used as a secondary antibody in Western blot at 1:8000
dilution. Phalloidin–TRITC (Sigma, St. Louis, MO), which
binds only to polymeric actin, was used at a concentration of
50 mg/ml in phosphate-buffered saline (PBS) for immunocy-
tochemistry. Affinity-purified fluorescein isothiocyanate
(FITC)– labeled goat antibodies against rabbit IgG that had
been absorbed with rabbit serum were purchased from
Chemicon International (Temecula, CA) and were used at
1:75 for immunocytochemistry. Aphidicolin (Wako, Osaka,
Japan) was used for cell synchronization. Low concentra-
tions of aphidicolin (1.25 mg/ml) can inhibit the growth of
eukaryotic cells by selectively inhibiting DNA synthesis with-
out interfering with mitochondrial DNA synthesis, RNA, pro-
tein and nucleic acid precursors synthesis, or other major
metabolic pathways [34].
Western Blot
Human brain tumor samples were obtained at the time of
surgery from patients at The Hospital for Sick Children.
There were seven posterior fossa medulloblastoma speci-
mens derived from children ages 3 to 14; a pilocytic low-
grade astrocytoma from the parietal lobe of a 7-year-old
male; an anaplastic astrocytoma from the thalamus of a
12-year-old female; and a glioblastoma multiforme from the
frontal lobe of a 10-year-old male. Nonneoplastic frontal and
temporal lobe specimens were obtained in two children
during the course of epilepsy surgery to excise the epileptic
focus. Nonneoplastic cerebellum from an 8-year-old male
was obtained as marginal tissue surrounding an arteriove-
nous malformation during the resection of this lesion. Ap-
proval to use these specimens was given by the REB, The
Hospital for Sick Children. Specimens were snap-frozen in
liquid nitrogen. Proteins were extracted from tissue samples
using 0.5% NP-40 lysis buffer and the lysate was loaded for
immunoblotting analysis as described below.
Cytosolic soluble fractions and insoluble membrane frac-
tions were extracted according to the procedure previously
described [10]. Briefly, cells were lysed in extraction buffer
[120 mM NaC1, 0.5% Nonidet P-40 (NP-40), 50 mM
Tris–HC1 (pH 8.0)] for 30 minutes on ice. The extracts were
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cleared by centrifugation at 14,000 rpm for 15 minutes at
4jC. Extracted soluble cytosolic proteins of 20 mg were
separated by electrophoresis on 10% sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) and sub-
jected to electrotransfer to polyvinylidene difluoride mem-
branes (Immobilon P; Millipore, Bedford, MA) by semidry
electrotransfer (0.8 mA/cm2). Blots were rehydrated and
blocked with 5% skim milk in PBS–0.1% Tween-20 at room
temperature for 1 hour. Primary and secondary antibody
incubations were performed in blocking solution at room
temperature for 1 hour. Horseradish peroxidase (HRP)–
conjugated secondary antibodies (Bio-Rad) were used
at 1:8000 dilution and detected with the enhanced chemo-
luminescence (ECL) system (Amersham, Oakville, Ontario,
Canada). Quantitative analysis of protein levels on immuno-
blots was performed by densitometry.
Immunocytochemistry and Confocal Microscopy
U373 MG cells were grown on eight-well chamber slides
(Nunc, Naperville, IL) and then fixed in 4% paraformaldehyde
in phosphate buffer (pH 7.2) for 40 minutes. Fixed cells
were washed with PBS and permeabilized with 0.02% Triton
X-100 in PBS for 2 minutes and blocked with 0.5% bovine
serum albumin in PBS for 1 hour. The cells were incubated
with the respective anti–septin polyclonal antibody (1:1000)
for 1 hour at room temperature. FITC-conjugated secondary
anti–rabbit IgG antibody (Pierce, Rockford, IL) was then
used at 1:100 dilution. Phalloidin–TRITC for actin staining
was used at a concentration of 50 mg/ml in PBS for 30
minutes. 4V,6-Diamidine-2V-phenylindole dihydrochloride
(DAPI) was used at the concentration of 1 mg/ml in mounting
medium for nuclear staining. Cell imaging was performed
using a Leica epifluoresence microscope equipped with Cool
Snap camera and software or a Leica confocal laser scan-
ning microscope.
Cell Cycle Synchronization and Flow Cytometry Analysis
Cell synchronization was achieved using aphidicolin.
Briefly, aphidicolin (1.25 mg/ml) was added to the growth
media 24 hours after plating 5  105 U373 MG cells in a
10-cm2 tissue culture plate. After 15 hours, the cells were
washed three times with growth media and were allowed to
progress through the cell cycle for 9 hours. This process was
repeated twice. Cells were harvested at 6-hour intervals
through one complete cell cycle. Cell synchronization was
confirmed by flow cytometry. For flow cytometric analysis,
cells were trypsinized, washed in PBS, and resuspended in
ice-cold 80% ethanol. The fixed cells were resuspended in
250 ml of propidium iodide (PI) solution (500 mg/ml PI in 3.8 M
sodium citrate at pH 7.0; Sigma), and 250 ml of RNase A (10
mg/ml prepared in 10 mM Tris–HCl at pH 7.5; Sigma) was
added to each sample and incubated in the dark at 37jC for
30 minutes. The stained cells were filtered through the lids of
Falcon polystyrene round-bottom tubes with cell strainer
caps. DNA content was analyzed on a Becton Dickinson
FACScan (Becton Dickinson, San Jose, CA). Percent cell
cycle phase was determined using Cell Fit software (Becton
Dickinson). Data were collected from at least 10,000 cells.
Construction of SEPT2–GFP Fusion Gene Expression
Plasmid
The full-length cDNAencoding humanSEPT2 in pGEX-2T
(718 bp) was used as previously described (wild-type
SEPT2) [10]. The DN SEPT2 mutant was obtained by
converting serine, the 51st amino acid of human SEPT2, to
asparagine (S51N SEPT2 mutant). In order to obtain the
SEPT2–GFP fusion gene (1.1 kb), we inserted the wild-type
and mutant SEPT2 fragments into the SmaI and HindIII sites
of the pEGFP-N1 vector (BD Clontech, Palo Alto, CA). The
SEPT2–GFP fusion gene was cloned into the inducible
pTRE2hyg expression vector (BD Clontech). Proper orien-
tation was determined by restriction digest. Protein expres-
sion was determined by Western blot using the SEPT2
antibody. The S51NSEPT2–GFP fusion gene in the pTRE2-
hyg vector was then used to investigate the role of SEPT2 on
U373 MG astrocytoma cells.
Transfection of SEPT2–GFP Fusion Gene into
U373-rtTA Cells
U373 MG cells were initially transfected with the pUHD
172-1 neoplasmid encoding the reverse transactivator (rtTA)
coding sequence downstream of the hCMV promoter/en-
hancer and neomycin resistance gene transfection reagent
[35,36]. All cell line transfections were performed using
Fugene 6 transfection reagent according to the manufactur-
er’s instructions (Roche Diagnostics, Basel, Switzerland).
Stable transfectants were selected and the expression of
the rtTA was determined using the VP16 antibody (Clontech)
in aWestern blot analysis. A high VP16-expressing cell clone
was selected and used to transfect the inducible SEPT2–
GFP or S51N–GFPmutant. The inducibility of the SEPT2 or
S51N protein expression was determined by Western blot
analysis after treatment of the cells with 4 mg/ml tetracycline
for 48 hours. The effects of wild-type and mutant SEPT2
fusion protein expression on the distribution of actin fila-
ments and cell morphology were determined by immunoflu-
orescence microscopy as described above.
To confirm the inhibitory function of S51N mutant SEPT2
on cytokinesis, DNA content was measured by fluorescence-
activated cell sorter (FACS) analysis in parental U373 MG
cells, transfected uninduced (Tet-off) cell clones, and trans-
fected tetracycline-induced cell clones for both wild-type and
S51N mutant SEPT2-expressing cells. The FACS analysis
gate was set to select GFP-positive cells with a green
fluorescence signal for Tet-on state cells. Tet-on cells are
harvested 7 days after treatment with tetracycline. The DNA
histograms from each assay contained data from over
10,000 cells.
Results
Septins Are Variably Expressed in Human Brain Tumor Cell
Lines and Specimens
Septin expression was detected predominantly in the
cytosolic fraction. There were no visible differences between
cytosolic septin expressions among the different cell lines,
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with the exception of SEPT3. Interestingly, SEPT3 was
highly expressed in cell lines and tumor samples of neuronal
origin such as medulloblastoma and supratentorial PNET
origin such as PFSK, but was not expressed in astrocytoma
cell lines (Figure 1). The anti–SEPT2 antibody identified an
immunoreactive band in all astrocytoma and medulloblasto-
ma cell lines examined.
The molecular masses of the septins examined ranged
from 35 to 65 kDa, which is in agreement with their predicted
sizes (Figure 2). There were at least four isoforms of SEPT9
in astrocytoma and medulloblastoma cell lines. The molec-
ular masses of SEPT9 isoforms ranged from 40 to 65 kDa.
In solid brain tumor specimens, SEPT2 protein was
detected in various brain tumors including low-grade astro-
cytomas, anaplastic astrocytomas, glioblastomas, and me-
dulloblastomas (Figure 3). Nonneoplastic brain tissues also
demonstrated SEPT2 expression. However, the expression
of SEPT2 in the frontal and temporal lobes and the cerebel-
lum was less than that observed in the primary astrocytic
tumors by densitometry. In addition, the expression of
SEPT2 in glioblastoma was greater than that in low-grade
astrocytoma. SEPT3 was expressed in all medulloblastoma
samples, and in nonneoplastic brain tissue. It was not
expressed in the astrocytic tumors except for one glioblas-
toma multiforme (Figure 3). Western blot analysis in addi-
tional 11 glioblastoma multiforme samples, however, could
not reveal SEPT3 expression (data not shown).
Subcellular Localization of Septins
Double immunofluorescence analysis for all septins
revealed a rather variable subcellular expression of the
respective septins. Although SEPT2 was immunoreactive
with short, linear or granular structures adjacent to actin
filaments within the cytoplasm and very prominent at the
plasma membrane in U373 cells (Figure 4A), SEPT3,
SEPT4, and SEPT6 were predominantly expressed in a
perinuclear fashion (Figure 4, B–D, respectively). SEPT7
showed strong cytoplasmic staining excluding the nuclear
region (Figure 4E ). SEPT3, SEPT4, SEPT6, and SEPT7
demonstrated a mutually exclusive immunolocalization with
actin. The expression of SEPT9 (data not shown) and
SEPT11 (Figure 4F ) was perinuclear and cytoplasmic with
some degree of overlap with actin. The immunofluorescence
staining for SEPT5 was weak around the nucleus (data not
shown).
SEPT2 was variably expressed during cell synchroniza-
tion with aphidicolin in SF-188 glioma cells (Figure 5A). In
interphase cells, endogenous SEPT2 was immunolocalized
to granular and short filamentous structures that overlap with
actin filaments. The perinuclear region was densely immu-
noreactive to SEPT2 (Figure 5A, upper ). In mitosis, SEPT2-
containing fibers were in close apposition to the actin-based
contractile ring and around the cleavage furrow between two
daughter cells (Figure 5A, lower ).
Septin Expression Is Maximal at G2-M Phase of
Synchronized U373 MG Astrocytoma Cells
By flow cytometry, aphidicolin arrested over 75% of U373
MG astrocytoma cells in the G2-M phase of the cell cycle,
with each cell containing two kinetoplasts. Most cells
arrested by aphidicolin were able to enter G1 phase 18 hours
after removal of aphidicolin (Figure 5B). The effects of cell
synchronization on SEPT2 expression at various time points
throughout the cell cycle are shown in Figure 6A. SEPT2
expression was maximal at G2-M phase in synchronized
U373 MG cells. By Western blot analysis, SEPT2 expression
Figure 1. Expression of human septins in human brain tumor cell lines and primary human fibroblasts. There were no visible differences between the expression of
septins among the different cell lines, except SEPT3. SEPT3 was not expressed in astrocytoma cell lines and primary human fibroblasts (F0068), but was
expressed by all medulloblastoma and supratentorial PNET cell lines. At least four isoforms of SEPT9 were observed in most of the cell lines.
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decreased 18 to 36 hours after removal of aphidicolin as cells
progressed through the cell cycle. At 42 to 48 hours after the
removal of aphidicolin, the expression of SEPT2 returned to
basal (steady state) levels similar to untreated control cells.
Expression of a DN SEPT2 Mutant Inhibits Cytokinesis
Western blot analysis of transfected U373 MG astrocyto-
ma cells induced for 48 hours with tetracycline revealed a 72-
kDA fusion protein with the anti–SEPT2 antibody (Figure 6B,
left panel ). When the membrane was reprobed with an anti–
GFP antibody, the same 72-kDa protein was identified
(Figure 6B, right panel ). The ratio of ectopic mutant to
normal SEPT2 was measured by densitometry of the above
Western blots, where it was found that the ratio for mutant to
normal expression ranged from 0.1 to 0.39, depending on the
degree of induction by tetracycline.
Successfully transfected cells could be readily identified
by virtue of the GFP tag by direct inspection with the
fluorescent microscope. As expected, the wild-type
SEPT2–GFP fusion protein was identified in short filamen-
tous structures and in a perinuclear distribution in a pattern
very similar to endogenous SEPT2 (data not shown). There
were no major differences in immunolocalization patterns of
actin and cellular morphology between parental U373 MG
cells and cells transfected with the wild-type SEPT2–GFP
fusion protein. By way of contrast, the mutant SEPT2–GFP
fusion protein appeared as large aggregates predominantly
in the perinuclear cytoplasm, or localized sporadically
throughout the cytoplasm but distinct from actin filaments,
which became prominent at the peripheral cytoplasm. In
dividing cells, expression of the mutant SEPT2 protein led
to the formation of numerous bizarre, multinucleated cells
(Figure 7A). By Western blot analysis, the expression of the
wild-type or mutant SEPT2–GFP fusion proteins did not
interfere with the expression levels of actin (data not shown).
FACS analysis of DNA content was compared in the
parental cell line, uninduced state, and induced state from
U373 MG wild-type cells and U373 MG-S51N cells
(Figure 7B). There was no difference in DNA content among
the parental cell line, the uninduced U373-S51N cells, and
Figure 2. Molecular mass determinations of the septins in human brain tumors. The molecular masses of the various septins range from 40 to 55 kDa. SEPT3 was
evaluated in a medulloblastoma cell line.
Figure 3. Expression of SEPT2 and SEPT3 in brain tissues and brain tumor samples. SEPT2 is variably expressed in SDS-soluble fractions of normal brain tissues
(frontal lobe, temporal lobe, and cerebellum), three astrocytomas of different histopathological grade, and seven medulloblastoma samples. SEPT2 expression in
astrocytomas is greater than that in normal brain tissues. SEPT2 expression in glioblastoma is greater than that in low-grade astrocytoma. SEPT3 is also
expressed in all samples except low-grade and malignant astrocytomas.
172 Septin Expression in Human Brain Tumours Kim et al.
Neoplasia . Vol. 6, No. 2, 2004
Figure 4. Subcellular localization of different septins in U373 astrocytoma cells. (A) U373 cells stained for SEPT2 show a perinuclear as well as membrane-bound
immunoreactivity colocalizing with the actin cytoskeleton. By way of contrast, immunoflourescence staining for SEPT3 (B), SEPT4 (C), and SEPT6 (D) was largely
confined to the perinuclear regions without significant overlap with actin staining. Immunoreactivity to SEPT7 (E) was detected only in the cytoplasm and was
mutually exclusive to the distribution of actin. Immunostains for SEPT11 (F) showed some colocalization with actin but remained predominantly nuclear or
perinuclear in distribution. Immunofluorescence microscopy of (A), (D), and (F),  250; (B), (C), and (E),  150 (green = immunoreactivity for the respective
septins stained with antiseptin antibody FITC; red = actin stained by Phalloidine–TRITC; yellow = colocalization of actin and the respective septin).
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the uninduced and induced U373 MG wild-type cells. In
contrast, tetracycline induction of U373-S51N cells led to a
significant increase in >2 N phase cells.
Discussion
In this study, we have examined the expression of eight
mammalian septins (SEPT2, SEPT3, SEPT4, SEPT5,
SEPT6, SEPT7, SEPT9, and SEPT11) in normal brain
tissues, a variety of astrocytoma and medulloblastoma cell
lines, and several solid brain tumor specimens. We have
confirmed the predicted molecular masses of the various
septins, which range from 35 to 65 kDa. By confocal double
immunofluorescence microscopy, SEPT2, SEPT9, and
SEPT11 were immunolocalized along with the actin micro-
filamentous system. Using aphidicolin to arrest cells in G2-M
phase, we show that SEPT2 is a cell cycle–regulated protein
essential for the process of cytokinesis in human astrocyto-
ma cells and localizes to the actin-based contractile ring
Figure 5. (A) Subcellular localization of endogenous SEPT2 in synchronized SF-188 MG cells. In interphase cells (upper), most of the endogenous SEPT2 were
found in short, linear structures localized close to actin filaments. However, SEPT2 immunoreactivity also existed amorphously in a perinuclear distribution. In
mitosis (lower), the SEPT2-containing filaments were in close apposition to the actin-based contractile ring, and amorphous SEPT2 proteins were strongly
concentrated around the cleavage furrow between two daughter cells (green = SEPT2; red = actin; yellow = colocalization of actin and SEPT2). Confocal
immunofluorescence microscopy, all  250. (B) Cell synchronization of U373 cells using aphidicolin. Flow cytometry showed that aphidicolin caused over 75% of
the cells to arrest in G2-M. Most of the cells arrested in G2-M phase by aphidicolin were then able to enter G1 phase 18 hours after removal of aphidicolin.
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during cytokinesis. Expression of a DN mutant SEPT2 gene
inhibits cytokinesis and results in multinucleated cells. Taken
together, these observations suggest a conserved require-
ment for SEPT2 in U373 astrocytoma cell division.
Despite considerable expression of septins in human
tissues, the precise function of the septin gene family
remains unclear. The most consistent function of septins is
an orthologous function in cytokinesis [1,4,6,37,38]. Inves-
tigations in yeast suggest that septins are putative cytoskel-
etal structures that play a role in cell division and are
localized exclusively to the bud neck throughout the entire
cell cycle, from bud emergence to cytokinesis. To date, only
one mammalian septin, SEPT2, has been shown to play a
role in cytokinesis [4].
Xue et al. [19] reported that SEPT3 is a brain-specific
septin that may be regulated by type I cGMP-dependent
protein kinase (PKG) in neurons. SEPT3 mRNA (5.0 kb) is
highly expressed in the brain and undetectable in 12 other
tissues [19]. These results suggest that the SEPT3 is pri-
marily a neuronal protein. In our study, we showed SEPT3
expression in human brain tissues from frontal and temporal
lobes and cerebellum, and in medulloblastoma specimens
and cell lines. However, we were unable to show any
significant expression of SEPT3 in astrocytoma cell lines or
specimens by Western blot analysis. Only 1 of 12 glioblas-
toma specimens examined expressed SEPT3. As for the
other septins, SEPT3, SEPT4, and SEPT6 showed a strong
perinuclear localization, whereas SEPT7 was exclusively
found in the cytoplasm sparing the nuclear region. SEPT9
and SEPT11 were diffusely distributed and demonstrated, to
some degree, colocalization with actin-based structures.
Precisely what these different patterns of septin immunoloc-
alization mean in astrocytoma cells awaits further study.
We have previously shown a relative increase in SEPT2
transcript levels from late G1 to G2-M phases and an
increase in SEPT2 protein levels from S to G2-M phases in
lovastatin- and nocodazole-synchronized U373 MG cells
[10]. In the present study, we used aphidicolin to synchronize
U373 MG cells in G2-M. By performing immunofluorescence
analysis of SEPT2 and actin in synchronized U373 MG cells,
we show that SEPT2 is found in granular and short filamen-
tous structures in interphase cells and colocalizes with actin
filaments. In contrast to actin, however, SEPT2 is also found
amorphously in a perinuclear distribution at this time. In
Figure 6. (A) SEPT2 expression in synchronized U373 MG astrocytoma cells. SEPT2 expression is maximal at the G2-M phase of synchronized U373 MG cells
(6–12 hours after removal of aphidicolin). By western blot analysis, SEPT2 expression diminishes in the time period 24 to 36 hours after removal of aphidicolin.
SEPT2 expression then returned to basal (steady state) levels 42 to 48 hours after removal of aphidicolin. (B) Inducible expression of wild-type and mutant SEPT2
in U373 MG cells. The inducibility of the wild-type or S51N mutant SEPT2–GFP fusion protein was determined by Western blot analysis using anti –SEPT2
antibodies (left) and anti –a-GFP antibody (right). Both antibodies detected the expected 72-kDa fusion protein 48 hours after induction with 1 to 20 g/ml
tetracycline.
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mitosis, SEPT2 immunoreactivity is found in close apposition
to the actin-based contractile ring. These data and the
Western blot time course study in U373 MG cells released
from aphidicolin support the notion that SEPT2 may be
expressed in a cell cycle–dependent fashion.
Using a technique complementary to antisense SEPT2
expression [10], we transfected U373 MG astrocytoma cells
with a DN mutant of SEPT2. This mutant was created by
converting amino acid 51 (serine) to asparagine [39]. In
contrast to our previous report [10], the DN approach used
here leads to the selection of stable cell clones that can be
induced to express mutant SEPT2 by virtue of the Tet-on
system. By immunocytochemistry, we show that mutant
SEPT2 expression leads to distinct cytological changes
characterized by incomplete cytokinesis, formation of long
cytoplasmic connections between dividing cells, and numer-
ous multinucleated cells. By FACS analysis, expression of
the mutant SEPT2 fusion protein led to a significant increase
in the number of multinucleated cells when compared to
controls. Our inability to block cytokinesis completely in all
glioma cells may relate to the differences in expression levels
between the endogenous SEPT2 protein and the ectopic
Figure 7. (A) Immunocytochemistry of mutant SEPT2 expressing U373 MG cells. S51N mutant SEPT2 cells undergo a distinct morphological change
characterized by incompletion of cytokinesis, formation of long cytoplasmic connections between dividing cells (upper), and multinucleated cells (lower)
(green = fusion protein by virtue of the GFP tag under confocal microscopy; red = actin stained by Phalloidine–TRITC; yellow = merge). Confocal
microscopy,  250. (B) DNA histograms after induction of DN SEPT2 mutant. DNA content is compared in the parental cell line, Tet-off state, and Tet-on state
from U373 MG wild-type cells and U373 MG-S51N cells. There is no difference in DNA content among the parental cell line, the uninduced U373-S51N cells, and
the uninduced and induced U373 wild-type cells. In contrast, in the Tet-on state, there is a significant increase in 4 N and >4 N phase cells in U373-S51N cells.
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mutant protein. The higher levels of the endogenous SEPT2
protein may have prevented the mutant protein from
squelching all of the normal protein functions. We recognize
the limitations of the expression of ectopic proteins in artificial
cell systems such as this. However, these results are similar
to those reported in S. cerevisiae and Drosophila when
septins in these species are mutated.
The relationship between SEPT2 and actin is important
for properly conducted and timed cytokinesis. Actin-based
contractile rings have been implicated in the cell division of
multiple eukaryotic organisms [40–42]. By immunocyto-
chemistry, we showed the colocalization of SEPT2 and actin
bundles in interphase cells, with strong consolidation around
actin-based contracting ring in mitotic cells of glioma cells.
These findings are similar to those reported previously in
other mammalian cells [4,10]. Lippincott and Li [43,44] used
time-lapsed microscopy to show that the septin structure
does not constrict during cytokinesis, unlike the actomyosin
ring. This goes along with our findings for all other septins,
which were not seen in relation to the contractile ring. Further
studies are necessary to determine whether the actin-based
contractile ring serves as a scaffold for septin assembly, or
whether a preformed septin scaffold recruits actin-based
contractile rings as in budding yeast [45].
In addition to their roles in cytokinesis, septins may
subserve other cellular functions. All mammalian septins
contain the same coiled-coil domain structure; however, they
exhibit even greater variations in the length and primary
structure of their N- and C-termini. The functions of the
septins may relate to the organization of specialized domains
within the cells. The availability of a septin domain suggests
that individual septins could participate in protein–protein
interactions [2]. Previous studies of SEPT2 and SEPT4 have
shown them to be present near the plasma membrane in a
filamentous form colocalizing with the actin cytoskeleton
[4,29]. We found SEPT4 only in a perinuclear distribution.
Recently, Surka et al. [32] reported that SEPT9 colocalized
with SEPT2, actin-based filaments, and microtubules in
interphase cells. Themolecular similarity between the septins
suggests a certain redundancy in their functions; however,
previous studies have shown restricted expression of at least
some septins. For example, SEPT5 is expressed primarily in
the brain. SEPT3, as stated above, is found in cells and
tissues of neuronal origin. Interestingly, SEPT2, which is
considered to be closely related to cell division, is broadly
expressed in most human organs that are predominantly
nonmitotic [4,46,47]. We recognize that our study is limited
by the availability of septin antibodies, and that antibody
specificity remains an important issue [48]. Still, none of the
septin antibodies cross-reacts with other septins, and all were
developed from unique sequences as entered in GenBank.
Studies on septins in yeast may provide us with clues to
their functions in mammalian cells. Yeast septin mutants
exhibit not only a multinuclear phenotype as a result of
defective cytokinesis, but also abnormalities in bud site
selection, cell polarity, and partitioning membrane domains
[2,49–52]. On the other hand, Drosophila septin, Sep1,
accumulates at the leading edge of migrating epithelial cells
[6]. Biochemical interactions of the mammalian SEPT4 and
SEPT5 complex with the sec6/sec8 complex [11] and with
syntaxin-1 [31] suggest possible involvement of the mem-
brane fusion machinery in mammalian cytokinesis, as has
been implicated in nematodes and plants [52–54]. The
mammalian septins may be involved in other cellular pro-
cesses including apoptosis [20], leukemogenesis and carci-
nogenesis [55–57], and neurodegeneration [15,58]. Although
information is fragmentary at this time, septins represent a
diverse and important family of proteins in dividing and
postmitotic cells. Our preliminary experiments suggest that
as a septin, SEPT2 may be a valuable new target for
strategies aimed at inhibiting astrocytoma cell division. Future
studies will focus on determining if the inhibition of the various
septins (alone and in combination) using various strategies,
such as antisense oligonucleotide, Tet-on inducible expres-
sion, or pTAT delivery, can serve as a rational approach to
blocking the growth of astrocytoma cells.
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